
=== FINAL SUMMARY ===

**One-sentence overview:** The financial trends from 2017 to 2019 show changes in risk-free interest rates, expected terms, volatility, and target prices, alongside details of stock options and compensation costs.

1. The risk-free interest rate increased from 1.9% in 2017 to 2.8% in 2019.
2. The expected term decreased from 7.0 years in 2017 to 3.9 years in 2019.
3. The expected volatility increased from 32.3% in 2017 to 51.9% in 2019.
4. The target price decreased from $67.39 in 2017 to $53.87 in 2019.
5. Stock options granted in 2019 were 585000 at $7.47 per share.
6. Stock options granted in 2018 were 325000 at $15.52 per share.
7. Stock options granted in 2017 were 320000 at $13.18 per share.
8. The total grant date fair value in 2019 was $2.4 million.
9. The total grant date fair value in 2018 was $5.0 million.
10. The total grant date fair value in 2017 was $4.3 million.
11. Canceled 1122500 performance-based stock options in 2019.
12. Concurrent grant of 748328 PRSUs for 13 employees in 2019.
13. Incremental compensation cost from modification was $8.2 million.
14. Remaining compensation expense as of September 27, 2019, was $2.8 million.

Answer Echoes:
- "Stock options granted in 2019: 585,000 at $7.47 per share"
- "Stock options granted in 2018: 325,000 at $15.52 per share"
- "Stock options granted in 2017: 320,000 at $13.18 per share"
- "Total grant date fair value in 2019: $2.4 million"
- "Total grant date fair value in 2018: $5.0 million"
- "Total grant date fair value in 2017: $4.3 million"
- "Canceled 1,122,500 performance-based stock options in 2019"
- "Concurrent grant of 748,328 PRSUs for 13 employees in 2019"
- "Incremental compensation cost from modification: $8.2 million"
- "Remaining compensation expense as of September 27, 2019: $2.8 million"

=== LOGS (per-agent) ===
{'TabuSynth': {'cot': '1. Compute the change in risk-free interest rate from '
                      '2017 to 2019.\n'
                      '2. Compute the change in expected term from 2017 to '
                      '2019.\n'
                      '3. Compute the change in expected volatility from 2017 '
                      'to 2019.\n'
                      '4. Compute the change in target price from 2017 to '
                      '2019.',
               'result': '[TREND] Risk-free interest rate increased from 1.9% '
                         'in 2017 to 2.8% in 2019.\n'
                         '[TREND] Expected term decreased from 7.0 years in '
                         '2017 to 3.9 years in 2019.\n'
                         '[TREND] Expected volatility increased from 32.3% in '
                         '2017 to 51.9% in 2019.\n'
                         '[TREND] Target price decreased from $67.39 in 2017 '
                         'to $53.87 in 2019.',
               'raw': '{\n'
                      '  "reasoning": "1. Compute the change in risk-free '
                      'interest rate from 2017 to 2019.\\n2. Compute the '
                      'change in expected term from 2017 to 2019.\\n3. Compute '
                      'the change in expected volatility from 2017 to '
                      '2019.\\n4. Compute the change in target price from 2017 '
                      'to 2019.",\n'
                      '  "bullets": [\n'
                      '    "[TREND] Risk-free interest rate increased from '
                      '1.9% in 2017 to 2.8% in 2019.",\n'
                      '    "[TREND] Expected term decreased from 7.0 years in '
                      '2017 to 3.9 years in 2019.",\n'
                      '    "[TREND] Expected volatility increased from 32.3% '
                      'in 2017 to 51.9% in 2019.",\n'
                      '    "[TREND] Target price decreased from $67.39 in 2017 '
                      'to $53.87 in 2019."\n'
                      '  ]\n'
                      '}'},
 'Contextron': {'cot': 'The TABLE CONTEXT provides trends in risk-free '
                       'interest rate, expected term, expected volatility, and '
                       'target price from 2017 to 2019, but does not include '
                       'specific details about stock options with market-based '
                       'vesting criteria. The CONTEXT fills these gaps by '
                       'providing specific figures for stock options granted '
                       'in fiscal years 2017, 2018, and 2019, including the '
                       'number of options, weighted average grant date fair '
                       'values, and total grant date fair values. It also '
                       'details the cancellation and modification of stock '
                       'options in 2019, including the incremental '
                       'compensation cost and remaining compensation expense. '
                       'This information directly addresses the questions by '
                       'providing exact numbers and descriptions of events '
                       'related to stock options and compensation costs.',
                'result': '- "Stock options granted in 2019: 585,000 at $7.47 '
                          'per share"\n'
                          '- "Stock options granted in 2018: 325,000 at $15.52 '
                          'per share"\n'
                          '- "Stock options granted in 2017: 320,000 at $13.18 '
                          'per share"\n'
                          '- "Total grant date fair value in 2019: $2.4 '
                          'million"\n'
                          '- "Total grant date fair value in 2018: $5.0 '
                          'million"\n'
                          '- "Total grant date fair value in 2017: $4.3 '
                          'million"\n'
                          '- "Canceled 1,122,500 performance-based stock '
                          'options in 2019"\n'
                          '- "Concurrent grant of 748,328 PRSUs for 13 '
                          'employees in 2019"\n'
                          '- "Incremental compensation cost from modification: '
                          '$8.2 million"\n'
                          '- "Remaining compensation expense as of September '
                          '27, 2019: $2.8 million"',
                'raw': 'The TABLE CONTEXT provides trends in risk-free '
                       'interest rate, expected term, expected volatility, and '
                       'target price from 2017 to 2019, but does not include '
                       'specific details about stock options with market-based '
                       'vesting criteria. The CONTEXT fills these gaps by '
                       'providing specific figures for stock options granted '
                       'in fiscal years 2017, 2018, and 2019, including the '
                       'number of options, weighted average grant date fair '
                       'values, and total grant date fair values. It also '
                       'details the cancellation and modification of stock '
                       'options in 2019, including the incremental '
                       'compensation cost and remaining compensation expense. '
                       'This information directly addresses the questions by '
                       'providing exact numbers and descriptions of events '
                       'related to stock options and compensation costs.\n'
                       '\n'
                       '- "Stock options granted in 2019: 585,000 at $7.47 per '
                       'share"\n'
                       '- "Stock options granted in 2018: 325,000 at $15.52 '
                       'per share"\n'
                       '- "Stock options granted in 2017: 320,000 at $13.18 '
                       'per share"\n'
                       '- "Total grant date fair value in 2019: $2.4 million"\n'
                       '- "Total grant date fair value in 2018: $5.0 million"\n'
                       '- "Total grant date fair value in 2017: $4.3 million"\n'
                       '- "Canceled 1,122,500 performance-based stock options '
                       'in 2019"\n'
                       '- "Concurrent grant of 748,328 PRSUs for 13 employees '
                       'in 2019"\n'
                       '- "Incremental compensation cost from modification: '
                       '$8.2 million"\n'
                       '- "Remaining compensation expense as of September 27, '
                       '2019: $2.8 million"'},
 'SummaCraft': {'cot': '(omitted)',
                'result': '**One-sentence overview:** The financial trends '
                          'from 2017 to 2019 show changes in risk-free '
                          'interest rates, expected terms, volatility, and '
                          'target prices, alongside details of stock options '
                          'and compensation costs.\n'
                          '\n'
                          '1. The risk-free interest rate increased from 1.9% '
                          'in 2017 to 2.8% in 2019.\n'
                          '2. The expected term decreased from 7.0 years in '
                          '2017 to 3.9 years in 2019.\n'
                          '3. The expected volatility increased from 32.3% in '
                          '2017 to 51.9% in 2019.\n'
                          '4. The target price decreased from $67.39 in 2017 '
                          'to $53.87 in 2019.\n'
                          '5. Stock options granted in 2019 were 585000 at '
                          '$7.47 per share.\n'
                          '6. Stock options granted in 2018 were 325000 at '
                          '$15.52 per share.\n'
                          '7. Stock options granted in 2017 were 320000 at '
                          '$13.18 per share.\n'
                          '8. The total grant date fair value in 2019 was $2.4 '
                          'million.\n'
                          '9. The total grant date fair value in 2018 was $5.0 '
                          'million.\n'
                          '10. The total grant date fair value in 2017 was '
                          '$4.3 million.\n'
                          '11. Canceled 1122500 performance-based stock '
                          'options in 2019.\n'
                          '12. Concurrent grant of 748328 PRSUs for 13 '
                          'employees in 2019.\n'
                          '13. Incremental compensation cost from modification '
                          'was $8.2 million.\n'
                          '14. Remaining compensation expense as of September '
                          '27, 2019, was $2.8 million.\n'
                          '\n'
                          'Answer Echoes:\n'
                          '- "Stock options granted in 2019: 585,000 at $7.47 '
                          'per share"\n'
                          '- "Stock options granted in 2018: 325,000 at $15.52 '
                          'per share"\n'
                          '- "Stock options granted in 2017: 320,000 at $13.18 '
                          'per share"\n'
                          '- "Total grant date fair value in 2019: $2.4 '
                          'million"\n'
                          '- "Total grant date fair value in 2018: $5.0 '
                          'million"\n'
                          '- "Total grant date fair value in 2017: $4.3 '
                          'million"\n'
                          '- "Canceled 1,122,500 performance-based stock '
                          'options in 2019"\n'
                          '- "Concurrent grant of 748,328 PRSUs for 13 '
                          'employees in 2019"\n'
                          '- "Incremental compensation cost from modification: '
                          '$8.2 million"\n'
                          '- "Remaining compensation expense as of September '
                          '27, 2019: $2.8 million"',
                'raw': '**One-sentence overview:** The financial trends from '
                       '2017 to 2019 show changes in risk-free interest rates, '
                       'expected terms, volatility, and target prices, '
                       'alongside details of stock options and compensation '
                       'costs.\n'
                       '\n'
                       '1. The risk-free interest rate increased from 1.9% in '
                       '2017 to 2.8% in 2019.\n'
                       '2. The expected term decreased from 7.0 years in 2017 '
                       'to 3.9 years in 2019.\n'
                       '3. The expected volatility increased from 32.3% in '
                       '2017 to 51.9% in 2019.\n'
                       '4. The target price decreased from $67.39 in 2017 to '
                       '$53.87 in 2019.\n'
                       '5. Stock options granted in 2019 were 585,000 at $7.47 '
                       'per share.\n'
                       '6. Stock options granted in 2018 were 325,000 at '
                       '$15.52 per share.\n'
                       '7. Stock options granted in 2017 were 320,000 at '
                       '$13.18 per share.\n'
                       '8. The total grant date fair value in 2019 was $2.4 '
                       'million.\n'
                       '9. The total grant date fair value in 2018 was $5.0 '
                       'million.\n'
                       '10. The total grant date fair value in 2017 was $4.3 '
                       'million.\n'
                       '11. Canceled 1,122,500 performance-based stock options '
                       'in 2019.\n'
                       '12. Concurrent grant of 748,328 PRSUs for 13 employees '
                       'in 2019.\n'
                       '13. Incremental compensation cost from modification '
                       'was $8.2 million.\n'
                       '14. Remaining compensation expense as of September 27, '
                       '2019, was $2.8 million.'}}
